Glycosuria
WikiDoc Resources for Glycosuria |
Articles |
---|
Most recent articles on Glycosuria |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Glycosuria at Clinical Trials.gov Clinical Trials on Glycosuria at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Glycosuria
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Glycosuria Discussion groups on Glycosuria Patient Handouts on Glycosuria Directions to Hospitals Treating Glycosuria Risk calculators and risk factors for Glycosuria
|
Healthcare Provider Resources |
Causes & Risk Factors for Glycosuria |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Glycosuria or glucosuria is an abnormal condition of osmotic diuresis due to excretion of glucose by the kidneys.
The most common cause of glycosuria is untreated diabetes mellitus. The condition occurs when plasma glucose levels rise above kidney threshold for glucose reabsorption. At this point, the excess plasma glucose will not be reabsorbed in the proximal tubule and is excreted in the urine. When the excess glucose is excreted in the urine, it makes water enter the urine due to high osmolarity of the urine. This leads to the characteristic symptom of high urine volumes.
Glycosuria can be either a physiologic response of the body to elevated blood glucose levels, such as alimentary glycosuria; or it can be a pathologic phenomenon.
When glycosuria occurs at normal plasma glucose concentrations due to decreased renal threshold for glucose reabsorption, it is reffered to as renal glycosuria.
Glycosuria has been targeted as a therapeutic option for diseases such as diabetes mellitus, as induction of glycosuria leads to better glycemic control and decreases risk of cardiovascular diseases in diabetic patients.
Causes
Drugs Causing Glycosuria
- Chlorpromazine
- Cidofovir
- Hydrochlorothiazide
- Prednisolone
- Streptozocin
- ACE Inhibitors (Captopril, Enalapril)
- SGLT2 Inhibitors
Other chemicals causing glycosuria
Historical Perspective
- Glycosuria was first discovered by von Mering and Minkowski in 1889.
Classification
- Glycosuria can be classified into the following groups, based on the etiology of glucose excretion in urine:
- Alimentary glycosuria
- Renal Glycosuria
- Diabetic glycosuria
- Iatrogenic glycosuria
Pathophysiology
- The pathogenesis of glycosuria is characterized by either increased plasma glucose or decreased proximal tubule threshold for glucose excretion.
- Genetic mutations can contribute to pathogenesis in glycosuria, especially renal glycosuria, these mutations include: SLC5A2 and HNF1A[1].
- When plasma glucose levels exceed 180 mg/mL, the excess glucose will not be reabsorbed and is excreted in urine. However, proximal tubule threshold for glucose reabsorbtion varies among individuals and in difference stages of one's life span.
Clinical Features
Simultaneous excretion of glucose and water into urine leads to:
Differentiating [disease name] from other Diseases
- [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
- [Differential dx1]
- [Differential dx2]
- [Differential dx3]
Epidemiology and Demographics
- The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
- In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].
Age
- Patients of all age groups may develop [disease name].
- [Disease name] is more commonly observed among patients aged [age range] years old.
- [Disease name] is more commonly observed among [elderly patients/young patients/children].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected with [disease name] than [gender 2].
- The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.
Race
- There is no racial predilection for [disease name].
- [Disease name] usually affects individuals of the [race 1] race.
- [Race 2] individuals are less likely to develop [disease name].
Risk Factors
- Genetic predisposition
- diabetes mellitus
- exposure to medications or chemicals causing glycosuria
Natural History, Complications and Prognosis
- Early clinical features include polyuria, polydipsia, hypoglycemia and weight loss due to excretion of glucose as a source of energy.
- Common complications of glycosuria include polyuria, polydipsia, and mild growth retardation.
- Glycosuria increases as the patients age due to decreased renal threshold for glucose excretion[2].
- Prognosis is generally excellent. There are no reports of mortality directly attributed to glycosuria.
Diagnosis
Diagnostic Criteria
Diagnosis of glycosuria depends on the type of glycosuria:
For renal glycosuria[2]:
- glycosuria in the face of normal blood glucose levels, normal glycosylated hemoglobin and normal free fatty acids
- glycosuria independent of carbohydrate consumption
- no diabetic symptoms
For Alimentary glycosuria[2]:
- normal fasting blood sugar
- normal 2-hours post-prandial blood glucose
- maximum blood glucose levels exceeding 180 mg/mL
Diabetic glycosuria:
- glycosuria in the setting of known diabeties mellitus
Symptoms
- Symptoms of glycosuriamay include the following:
- polyuria
- polydipsia
- weight loss
Physical Examination
Patients with glycosuria generally appear normal in physical examination.
In specific conditions, such as pregnancy or starvation, patients may:
- appear dehydrated
- have ketosis
Laboratory Findings
- There are no specific laboratory findings associated with [disease name].
- A [positive/negative] [test name] is diagnostic of [disease name].
- An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
- Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
Imaging Findings
- There are no [imaging study] findings associated with [disease name].
- [Imaging study 1] is the imaging modality of choice for [disease name].
- On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
- [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].
Other Diagnostic Studies
- [Disease name] may also be diagnosed using [diagnostic study name].
- Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].
Treatment
Medical Therapy
- There is no treatment for [disease name]; the mainstay of therapy is supportive care.
- The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
- [Medical therapy 1] acts by [mechanism of action 1].
- Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].
Surgery
- Surgery is the mainstay of therapy for [disease name].
- [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
- [Surgical procedure] can only be performed for patients with [disease stage] [disease name].
Prevention
- There are no primary preventive measures available for [disease name].
- Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
- Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].
References
See also
Template:Abnormal clinical and laboratory findings